These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Do antidepressants have any potential to cause addiction? Haddad P J Psychopharmacol; 1999; 13(3):300-7. PubMed ID: 10512092 [TBL] [Abstract][Full Text] [Related]
24. [Stopping antidepressants: withdrawal symptoms and rebound effects : Review and practical recommendations]. Bschor T; Bonnet U; Pitzer M; Baethge C; Lieb K; Gertz HJ; Müller-Oerlinghausen B Nervenarzt; 2022 Jan; 93(1):93-101. PubMed ID: 34978577 [TBL] [Abstract][Full Text] [Related]
25. Antidepressants, withdrawal, and addiction; where are we now? Jauhar S; Hayes J; Goodwin GM; Baldwin DS; Cowen PJ; Nutt DJ J Psychopharmacol; 2019 Jun; 33(6):655-659. PubMed ID: 31111764 [TBL] [Abstract][Full Text] [Related]
26. Illness risk following rapid versus gradual discontinuation of antidepressants. Baldessarini RJ; Tondo L; Ghiani C; Lepri B Am J Psychiatry; 2010 Aug; 167(8):934-41. PubMed ID: 20478876 [TBL] [Abstract][Full Text] [Related]
27. Antidepressant discontinuation syndrome: A state-of-the-art clinical review. Fornaro M; Cattaneo CI; De Berardis D; Ressico FV; Martinotti G; Vieta E Eur Neuropsychopharmacol; 2023 Jan; 66():1-10. PubMed ID: 36345093 [TBL] [Abstract][Full Text] [Related]
28. Antidepressant Tapering Is Not Routine But Could Be. Phelps J; Nguyen J; Coskey OP J Am Board Fam Med; 2023 Feb; 36(1):145-151. PubMed ID: 36653116 [TBL] [Abstract][Full Text] [Related]
29. Discontinuation syndrome associated with paroxetine in depressed patients: a retrospective analysis of factors involved in the occurrence of the syndrome. Himei A; Okamura T CNS Drugs; 2006; 20(8):665-72. PubMed ID: 16863271 [TBL] [Abstract][Full Text] [Related]
30. Prospective studies of adverse events related to antidepressant discontinuation. Fava M J Clin Psychiatry; 2006; 67 Suppl 4():14-21. PubMed ID: 16683858 [TBL] [Abstract][Full Text] [Related]
33. Hallucination induced by paroxetine discontinuation in patients with major depressive disorders. Yasui-Furukori N; Kaneko S Psychiatry Clin Neurosci; 2011 Jun; 65(4):384-5. PubMed ID: 21489048 [TBL] [Abstract][Full Text] [Related]
34. Discontinuation symptoms in depression and anxiety disorders. Baldwin DS; Montgomery SA; Nil R; Lader M Int J Neuropsychopharmacol; 2007 Feb; 10(1):73-84. PubMed ID: 16359583 [TBL] [Abstract][Full Text] [Related]
35. Antidepressant noncompliance as a factor in the discontinuation syndrome. Kaplan EM J Clin Psychiatry; 1997; 58 Suppl 7():31-5; discussion 36. PubMed ID: 9219492 [TBL] [Abstract][Full Text] [Related]
36. Physicians' knowledge of antidepressant withdrawal effects: a survey. Young AH; Currie A J Clin Psychiatry; 1997; 58 Suppl 7():28-30. PubMed ID: 9219491 [TBL] [Abstract][Full Text] [Related]
37. Brain Zaps: An Underappreciated Symptom of Antidepressant Discontinuation. Papp A; Onton JA Prim Care Companion CNS Disord; 2018 Dec; 20(6):. PubMed ID: 30605268 [TBL] [Abstract][Full Text] [Related]
38. Antidepressant withdrawal symptoms treated with anticholinergic agents. Dilsaver SC; Feinberg M; Greden JF Am J Psychiatry; 1983 Feb; 140(2):249-51. PubMed ID: 6849449 [TBL] [Abstract][Full Text] [Related]
39. [Antidepressant discontinuation syndrome in clinical and laboratory studies--implications for clinicians and patients]. Heitzman J; Solak M Psychiatr Pol; 2009; 43(5):545-55. PubMed ID: 20214096 [TBL] [Abstract][Full Text] [Related]
40. Discontinuing Antidepressants: How Can Clinicians Guide Patients and Drive Research? Jha MK J Clin Psychiatry; 2019 Nov; 80(6):. PubMed ID: 31774944 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]